Wells Fargo raised the firm’s price target on Delek US (DK) to $53 from $43 and keeps an Overweight rating on the shares. The firm says the company quantified SRE benefits and offered a SoP valuation. Even without full credit for EPO, Wells sees ongoing upside to shares.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK: